Bafna Pharmaceuticals IPO vs Sejal IPO

Comparision between Bafna Pharmaceuticals IPO and Sejal IPO.

IPO Details

Bafna Pharmaceuticals IPO is a Mainline Book Built Issue IPO proposed to list at BSE while Sejal IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.

	Bafna Pharmaceuticals IPO	Sejal IPO
Logo
Issue Category	Mainline	Mainline
Issue Type	IPO	IPO
Process Type	Fixed Price Issue	Book Built Issue
Listing At	BSE	BSE, NSE
Lead Managers	Keynote Financial Services Ltd Ashika Capital Ltd	Saffron Capital Advisors Private Limited
Registrar	Cameo Corporate Services Limited	Link Intime India Private Ltd
Market Maker
DRHP	DRHP	DRHP
RHP	RHP	RHP
Anchor Investor
IPO Allotment URL	IPO Allotment URL	IPO Allotment URL

Issue Size and Price

The total issue size of Bafna Pharmaceuticals IPO is up to ₹25.60 Cr whereas the issue size of the Sejal IPO is up to ₹105.73 Cr. The final issue price of Bafna Pharmaceuticals IPO is ₹40.00 per share and of Sejal IPO is ₹115.00 per share.

	Bafna Pharmaceuticals IPO	Sejal IPO
Face Value	₹10 per share	₹10 per share
Issue Price (Lower)		₹105.00 per share
Issue Price (Upper)		₹115.00 per share
Issue Price (Final)	₹40.00 per share	₹115.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size		60 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total	64,00,000 shares	91,94,155 shares
Issue Size Total (Amount)	up to ₹25.60 Cr	up to ₹105.73 Cr

IPO Timetable

Bafna Pharmaceuticals IPO opens on May 27, 2008, while Sejal IPO opens on Jun 09, 2008. The closing date of Bafna Pharmaceuticals IPO and Sejal IPO is May 30, 2008, and Jun 12, 2008, respectively.

	Bafna Pharmaceuticals IPO	Sejal IPO
Anchor Bid Date
Issue Open	May 27, 2008	Jun 09, 2008
Issue Close	May 30, 2008	Jun 12, 2008
Basis Of Allotment (Tentative)
Initiation of Refunds (Tentative)
Credit of Share (Tentative)
Listing date (Tentative)
Anchor Lockin End date 1
Anchor Lockin End date 2

Financials

Bafna Pharmaceuticals IPO P/E ratio is , as compared to Sejal IPO P/E ratio of .

Bafna Pharmaceuticals IPO

Sejal IPO

Financial

Particulars	For the year/period ended (Rs. in lacs)
	30-Jun-07	31-Mar-07	31-Mar-06	31-Mar-05	31-Mar-04
Total Income	432.02	3861.96	2136.47	2662.65	1521.33
Profit After Tax (PAT)	49.70	104.23	92.27	89.81	44.51

Particulars	For the year/period ended (Rs. in lacs)
	30-Sep-07	31-Mar-07	31-Mar-06	31-Mar-05	31-Mar-04	31-Mar-03
Total Income	2911.53	3935.68	3072.16	2448.38	2001.69	1717.07
Profit After Tax (PAT)	248.43	278.22	222.87	262.46	169.04	20.10

Promoter Shareholding (Pre-Issue)

71.07%

77.58%

Promoter Shareholding (Post-Issue)

42.6%

52.11%

P/E Ratio

Market Cap

ROE

ROCE

Debt/Equity

EPS

RoNW

10.65%%

20.38%%

Shares Offered

In the Bafna Pharmaceuticals IPO retail investors (RII) are offered while in Sejal IPO retail investors are offered . Qualified institutional buyers (QIB) are offered in Bafna Pharmaceuticals IPO and in Sejal IPO.

	Bafna Pharmaceuticals IPO	Sejal IPO
Anchor Investor Reserveration
Market Maker Reserveration
QIB
NII
RII
Employee
Others
Total

Bids Received (Subscription)

Bafna Pharmaceuticals IPO subscribed in total, whereas Sejal IPO subscribed 9.90x.

	Bafna Pharmaceuticals IPO	Sejal IPO
QIB (times)		4.26x
NII (times)		33.17x
Big NII (times)
Small NII (times)
RII (times)		7.98x
Employee (times)
Other (times)
Total (times)		9.90x

Compare with others

Bafna Pharmaceuticals IPO	Sejal IPO
Archidply IPO	KSK Energy IPO
First Winner IPO	Somi Conveyor IPO
Sejal IPO	Lotus Eye Care IPO
Avon Weighing IPO	Archidply IPO
MCX IPO	First Winner IPO
Niraj Cement Structurals IPO	Avon Weighing IPO
Anu Laboratories IPO	MCX IPO
Gokul Refoils IPO	Bafna Pharmaceuticals IPO
Aishwarya Telecom IPO	Niraj Cement Structurals IPO
Titagarh Wagons IPO	Anu Laboratories IPO

Comments

Add a public comment...